Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 2009.00 -0.95 (-0.05%) | NSE 2009.70 -0.90 (-0.04%) | Trade | Add

BSE Live

Dec 29, 16:01

2009.00 -0.95 (-0.05%)

Volume

AVERAGE VOLUME

5-Day

25,495

10-Day

17,687

30-Day

23,820

5,497

Prev. Close

2009.95
Open Price

2043.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 29, 15:44

2009.70 -0.90 (-0.04%)

Volume

AVERAGE VOLUME

5-Day

684,687

10-Day

522,249

30-Day

979,576

266,984

Prev. Close

2010.60
Open Price

2012.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2009.70 (452)

Financials

Print/Copy to Excel : Go

Balance Sheet of Glenmark Pharma (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	26.98	25.05	24.87	24.01	23.74
Total Share Capital	26.98	25.05	24.87	24.01	43.74
Reserves and Surplus	1,746.43	1,204.92	1,003.38	426.15	275.01
Total Reserves and Surplus	1,746.43	1,204.92	1,003.38	426.15	275.01
Total Shareholders Funds	1,773.42	1,229.97	1,028.25	450.16	318.76
NON-CURRENT LIABILITIES
Long Term Borrowings	617.45	234.51	240.38	453.96	519.22
Deferred Tax Liabilities [Net]	32.77	41.12	104.20	79.91	49.99
Other Long Term Liabilities	0.00	0.00	0.00	0.00	0.00
Long Term Provisions	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	650.22	275.63	344.59	533.87	569.21
CURRENT LIABILITIES
Short Term Borrowings	136.96	826.85	284.16	453.52	208.82
Trade Payables	128.65	149.05	176.37	124.14	73.33
Other Current Liabilities	66.98	78.76	96.38	62.83	36.99
Short Term Provisions	17.39	15.94	5.61	0.67	0.81
Total Current Liabilities	349.98	1,070.60	562.53	641.16	319.95
Total Capital And Liabilities	2,773.62	2,576.20	1,935.36	1,625.19	1,207.93
ASSETS
NON-CURRENT ASSETS
Tangible Assets	138.92	123.59	287.07	233.67	214.38
Intangible Assets	51.49	49.22	80.46	43.24	38.18
Capital Work-In-Progress	46.88	32.45	225.57	156.30	57.56
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	237.29	205.26	593.10	433.21	310.12
Non-Current Investments	992.92	237.63	196.70	139.10	43.56
Deferred Tax Assets [Net]	9.67	8.81	8.65	3.68	3.14
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	1,239.88	451.69	798.45	575.99	356.83
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	150.40	130.31	273.63	218.20	138.89
Trade Receivables	330.09	409.82	595.16	420.99	282.79
Cash And Cash Equivalents	5.08	11.69	11.18	11.39	89.16
Short Term Loans And Advances	1,048.17	1,571.65	256.95	398.63	340.26
OtherCurrentAssets	0.00	1.03	0.00	0.00	0.00
Total Current Assets	1,533.74	2,124.50	1,136.92	1,049.21	851.10
Total Assets	2,773.62	2,576.20	1,935.36	1,625.19	1,207.93
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	966.61	965.00	587.54	131.23	4.82
CIF VALUE OF IMPORTS
Raw Materials	15.04	11.43	124.29	76.65	36.39
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	7.79	18.26	22.00	9.32	11.53
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	59.68	52.82	34.57	38.20	34.74
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	0.01	--	0.02	0.07	0.04
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	264.91	206.85	677.41	303.76	140.81
Other Earnings	30.43	16.52	6.80	15.39	11.53
BONUS DETAILS
Bonus Equity Share Capital	15.84	15.84	15.84	15.84	15.84
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.04	0.20	0.24	0.16	0.13
Non-Current Investments Unquoted Book Value	992.88	237.59	196.66	139.05	43.52
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--